We are live on ! Find out more
VTYX

Ventyx Biosciences

Delisted

VTYX was delisted on the 3rd of March, 2026.

116 hedge funds and large institutions have $51.1M invested in Ventyx Biosciences in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 34 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

6% less funds holding

Funds holding: 124116 (-8)

14.59% less ownership

Funds ownership: 77%62.42% (-15%)

35% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 23

36% less call options, than puts

Call options by funds: $39K | Put options by funds: $61K

57% less capital invested

Capital invested by funds: $119M → $51.1M (-$68.2M)

Holders
116
Holders Change
-8
Holders Change %
-6.45%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
15
Increased
39
Reduced
34
Closed
23
Calls
$39K
Puts
$61K
Net Calls
-$22K
Net Calls Change
+$154K
Name Holding Trade Value Shares
Change
Change in
Stake
UB
101
UMB Bank
Missouri
$2.3K
PNC Financial Services Group
102
PNC Financial Services Group
Pennsylvania
$2.26K +$3.32K +1,935 +5,691%
Simplex Trading
103
Simplex Trading
Illinois
$2K -$252K -147,041 -98%
AB
104
Amalgamated Bank
New York
$2K
Russell Investments Group
105
Russell Investments Group
United Kingdom
$1.78K +$2.17K +1,262 +435%
SCM
106
Sterling Capital Management
North Carolina
$1.26K -$1.67K -972 -47%
Nisa Investment Advisors
107
Nisa Investment Advisors
Missouri
$1.17K +$767 +447 +79%
TWD
108
True Wealth Design
Ohio
$957 +$1.4K +814 +4,522%
Optiver Holding
109
Optiver Holding
Netherlands
$927 -$402 -234 -23%
CA
110
Clearstead Advisors
Ohio
$575
EWA
111
EverSource Wealth Advisors
Alabama
$445 +$664 +387 New
RA
112
Rise Advisors
New York
$376 +$561 +327 New
SS
113
SBI Securities
Japan
$159
FFA
114
Farther Finance Advisors
California
$107 -$1.1K -639 -86%
IA
115
IFP Advisors
Florida
$8
DM
116
Deerfield Management
New York
-$1.17M -534,737 Closed
Jacobs Levy Equity Management
117
Jacobs Levy Equity Management
New Jersey
-$1.05M -479,212 Closed
Two Sigma Investments
118
Two Sigma Investments
New York
-$1.04M -476,291 Closed
UOC
119
UBS O'Connor
Illinois
-$534K -244,000 Closed
VF
120
Virtu Financial
New York
-$189K -86,385 Closed
American Century Companies
121
American Century Companies
Missouri
-$147K -67,329 Closed
Squarepoint
122
Squarepoint
New York
-$138K -62,990 Closed
EGM
123
Engineers Gate Manager
New York
-$58.7K -26,797 Closed
MIM
124
MetLife Investment Management
New Jersey
-$58.5K -26,731 Closed
BFG
125
Bleakley Financial Group
New Jersey
-$50.6K -23,083 Closed

VTYX Hedge Fund Activity: Q1 2025 in Review

116 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q1 2025, worth a combined $51.1M — down 57% from $119M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of VTYX and 15 opened new positions — a net loss of 8 holders — while 34 trimmed existing stakes and 39 added.

The largest buyer was Point72 Asset Management, adding an estimated $4.21M. The largest seller was UBS Group, cutting an estimated $5.96M.

  • 116 institutional investors held Ventyx Biosciences (VTYX) as of Q1 2025, down from 124 in Q4 2024.
  • Funds reported $51.1M of Ventyx Biosciences stock for Q1 2025, down 57% quarter-over-quarter.
  • 15 funds opened new Ventyx Biosciences positions in Q1 2025 and 23 closed out, a net change of -8 holders.
  • The largest Ventyx Biosciences buyer in Q1 2025 was Point72 Asset Management, an estimated $4.21M added.
  • The largest Ventyx Biosciences seller in Q1 2025 was UBS Group, an estimated $5.96M sold.

Based on aggregated 13F filings for Q1 2025.